[1]黄燕,邹天骏,罗雪菲,等.基于网络药理学探讨余甘子叶总黄酮抗结直肠癌的分子机制及活性成分[J].中国中医药信息杂志,2021,28(9):44-48.[doi:10.19879/j.cnki.1005-5304.202009104]
 HUANG Yan,ZOU Tianjun,LUO Xuefei,et al.Molecular Mechanism and Active Ingredients of Total Flavonoids from Phyllanthus emblica Leaves Against Colorectal Cancer Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2021,28(9):44-48.[doi:10.19879/j.cnki.1005-5304.202009104]
点击复制

基于网络药理学探讨余甘子叶总黄酮抗结直肠癌的分子机制及活性成分

参考文献/References:

[1] GORDALIZA M. Natural products as leads to anticancer drugs[J]. Clinical and Translational Oncology,2007,9(12):767-776.

[2] KHAZIR J, RILEY D L, PILCHER L A, et al. Anticancer agents from diverse natural sources[J]. Natural Product Communications,2014, 9(11):1655-1669.

[3] 周涛,邱德文.民族药余甘子的本草药学概况[J].贵阳中医学院学报, 2002,24(3):3-6.

[4] 国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2015:179.

[5] 侯开卫.余甘子化学成分及其在民族民间传统医药中的应用[J].中国民族民间医药杂志,2002,11(6):345-346.

[6] 王捷,叶勇,梁浩,等.余甘子叶的研究概况[J].中国民族民间医药, 2018,27(4):40-44.

[7] 陈文雅,钟振国,张雯艳.余甘子叶的化学成分与药理作用研究概况[J].广西中医药大学学报,2016,19(3):82-83.

[8] 曾春兰,钟振国.余甘子叶提取物体外抗肿瘤作用研究[J].时珍国医国药,2008,19(3):580-583.

[9] 黄燕,罗雪菲,李舒,等.余甘子叶提取物对荷瘤小鼠抑瘤及免疫功能影响的研究[J].时珍国医国药,2011,22(9):2204-2206.

[10] 陈文雅.余甘子叶总黄酮的抗肿瘤作用及其机制研究[D].南宁:广西中医药大学,2017.

[11] PEI L, BAO Y, LIU S, et al. Material basis of Chinese herbal formulas explored by combining pharmacokinetics with network pharmacology[J]. PLoS One,2013,8(2):e57414.

[12] ZHANG H, BEREZOV A, WANG Q, et al. ErbB receptors:from oncogenes to targeted cancer treatment[J]. The Journal of Clinical Investigation,2007,117(8):2051-2058.

[13] 李莹,田驰,王磊,等.小分子表皮生长因子受体酪氨酸激酶抑制剂的研究进展[J].肿瘤药学,2016,6(2):7-14.

[14] CHEN C, ZHOU J, JI C. Quercetin:a potential drug to reverse multidrug resistance[J]. Life Sciences,2010,87(11/12):333-338.

[15] SREELAKSHMI V, RAJ N, ABRAHAM A. Evaluation of the drug-like properties of kaempferol, chrysophanol and emodin and their interactions with EGFR tyrosine kinase-an in silico approach[J]. Natural Product Communications,2017,12(6):1934578X1701200621.

[16] LEE H S, CHO H J, KWON G T, et al. Kaempferol downregulates insulin-like growth factor-I receptor and ErbB3 signaling in HT-29 human colon cancer cells[J]. Journal of Cancer Prevention, 2014,19(3):161.

相似文献/References:

[1]姜毅,金晓炜,张建玲,等.血清肿瘤标志物的变化与结直肠癌中医辨证分型相关性研究[J].中国中医药信息杂志,2011,18(3):27.[doi:10.3969/j.issn.1005-5304.2011.03.011]
 JIANG Yi,JIN Xiao-wei,ZHANG Jian-ling,et al.Correlation of Changes of Blood Serum Tumor Markers and TCM Syndrome Differentiation of Colorectal Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):27.[doi:10.3969/j.issn.1005-5304.2011.03.011]
[2]方明治,李敏.FOLFOX-4方案联合鸦胆子油乳治疗转移性结直肠癌疗效及不良反应观察[J].中国中医药信息杂志,2008,15(11):74.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):74.
[3]钱垠,方明治,黄欣.论湿邪在结直肠癌发病中的作用和地位[J].中国中医药信息杂志,2011,18(7):82.[doi:10.3969/j.issn.1005-5304.2011.07.036]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):82.[doi:10.3969/j.issn.1005-5304.2011.07.036]
[4]李斯文,张亮.结直肠癌术后吻合口炎中医药治疗思路[J].中国中医药信息杂志,2011,18(11):97.[doi:10.3969/j.issn.1005-5304.2011.11.046]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):97.[doi:10.3969/j.issn.1005-5304.2011.11.046]
[5]魏东,高辉,彭晶晶,等.参芪归脾汤加味防治结直肠癌化疗后胃肠道毒副反应疗效观察[J].中国中医药信息杂志,2012,19(7):67.[doi:10.3969/j.issn.1005-5304.2012.07.028]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(9):67.[doi:10.3969/j.issn.1005-5304.2012.07.028]
[6]钱垠,方明治,朱翔.扶正升白口服液提高结直肠癌术后化疗患者耐受性的临床观察[J].中国中医药信息杂志,2012,19(11):74.[doi:10.3969/j.issn.1005-5304.2012.11.032]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(9):74.[doi:10.3969/j.issn.1005-5304.2012.11.032]
[7]李艺,李俊,高秉承,等.清肠汤直肠滴注治疗结直肠癌术后吻合口炎临床观察[J].中国中医药信息杂志,2012,19(4):81.[doi:10.3969/j.issn.1005-5304.2012.04.036]
 [J].zhongguo zhongyiyao xinxi zazhi,2012,19(9):81.[doi:10.3969/j.issn.1005-5304.2012.04.036]
[8]周昱岐,叶敏,吕灿,等.消痰散结方对人结直肠癌HCT116细胞增殖和凋亡及Caspase3蛋白表达的影响[J].中国中医药信息杂志,2015,22(3):60.[doi:10.3969/j.issn.1005-5304.2015.03.016]
 ZHOU Yu-qi,YE Min,LV Can,et al.Effect of Xiaotan Sanjie Recipe on Proliferation and Apoptosis of HCT116 Cell and Expression of Caspase3 Protein[J].zhongguo zhongyiyao xinxi zazhi,2015,22(9):60.[doi:10.3969/j.issn.1005-5304.2015.03.016]
[9]罗吉,李勇敏,简小兰,等.健脾消癌方对转化生长因子-β1诱导的SW620细胞上皮间质转化的影响[J].中国中医药信息杂志,2018,25(2):42.[doi:10.3969/j.issn.1005-5304.2018.02.010]
 LUO Ji,LI Yong-min,JIAN Xiao-lan,et al.Effects of Jianpi Xiaoai Prescription on Epithelial-mesenchymal Transition of Colorectal Cancer Cell SW620 Induced by TGF-β1[J].zhongguo zhongyiyao xinxi zazhi,2018,25(9):42.[doi:10.3969/j.issn.1005-5304.2018.02.010]
[10]严卿莹,叶晔,冯冠,等.基于网络药理学的虎杖治疗结直肠癌作用机制研究[J].中国中医药信息杂志,2019,26(4):96.[doi:10.3969/j.issn.1005-5304.2019.04.020]
 YAN Qingying,YE Ye,FENG Guan,et al.Study on Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treatment of Colorectal Cancer Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2019,26(9):96.[doi:10.3969/j.issn.1005-5304.2019.04.020]

备注/Memo

基金项目:广西中医药大学校级课题(2015MS016)

更新日期/Last Update:

2021-08-18